Inhalation Sciences contracts AQ Group to scale up production
Inhalation Sciences (ISAB) and AQ M-Tech AB in Uppsala have entered into an agreement on the production of ISAB products. The contract is an important step in ISAB's commercialization process, creating good conditions for ISAB to meet increased demand for its products.
Recently listed on Stockholm’s AktieTorget, ISAB develops and sells novel lab equipment for inhalation R&D that measures how particles in inhaled air affect our health. The company's main product, PreciseInhale, has been sold to and installed at a total of eight leading companies and academic research institutes, including Astra Zeneca, Chiesi and Fraunhofer. ISAB is now entering a phase of increased sales.
AQ M-Tech AB is a part of AQ Group AB. AQ M-Tech specializes in the development, construction and manufacturing of tailored technology solutions and products. AQ M-Tech AB is a medtech company within AQ group specializing in medical products and requirements.
ISAB CEO Fredrik Sjövall: "AQ M-Tech has been involved in producing parts of our products for a long time and we already have a very good relationship. Expanding AQ M-Tech's commitment is an important step in accelerating the commercialization rate of PreciseInhale. We expect it to lead to lower production costs and increased margins. AQ M-Tech has all the qualities we’d wish for in a production partner, with deep expertise in mechanics, electronics and advanced assembly."
AQ M-Tech’s CEO Tobias Hammar: ”We’re proud and delighted ISAB has chosen us as a supplier. ISAB’s products fit well with our strategy of being a production partner in the field of advanced medical products.”
For more information about Inhalation Sciences please contact: Fredrik Sjövall, CEO Email: firstname.lastname@example.org Phone: +46 (0)70 64 508 75Press release in PDF format